Ocular Therapeutix, Inc. has grown revenue 0.23% a year over three years and 19% a year over five. Revenue growth, 3-year annual rate: +0.23% (Biotechnology median +21%). Revenue growth, 5-year rate: +19%, growth has slowed since the five-year average. Years of annual history on file: 14, FY2012 to FY2025, as filed.

OCULOcular Therapeutix, Inc.

HealthcareUSD

$10.77

$6.8852 weeks$16.11

Is it growing?

Is OCUL growing?

Ocular Therapeutix, Inc. has grown revenue 0.23% a year over three years and 19% a year over five.

+0.23%

Revenue growth, 3-year annual rate · Biotechnology median +21% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +19%
Revenue growth, 5-year rate · +0.23% over three · growth has slowed since the five-year average
Years of annual history on file: 14
Years of annual history on file · FY2012 to FY2025, as filed

Details›